Gene · 429
Papers4,495
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
281 to 300 of 4,495
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Prognostic significance of tertiary lymphoid structures in gastric neuroendocrine carcinoma with association to delta-like ligand 3 and neuroendocrine expressions. | Gastric Cancer | 2025 | 39352632 | PubTator, text mining | PubMed |
| POU4F3 Is a Sensitive and Specific Marker of Merkel Cell Carcinoma. | Mod Pathol | 2025 | 39341281 | PubTator, text mining | PubMed |
| Identification of HEPACAM2 as a novel and specific marker of small cell carcinoma. | Cancer | 2025 | 39301750 | PubTator, text mining | PubMed |
| Identifying Reproducible Transcription Regulator Coexpression Patterns with Single Cell Transcriptomics. | bioRxiv | 2025 | 38559016 | PubTator, text mining | PubMed |
| Heterogeneity of molecular subtyping and therapy-related marker expression in primary tumors and paired lymph node metastases of small cell lung cancer. | Virchows Arch | 2025 | 38347268 | PubTator, text mining | PubMed |
| The molecular determinants of phenotypic plasticity in homeostasis and neoplasia. | Cancer Heterog Plast | 2024 | 40994652 | PubTator, text mining | PubMed |
| Methylation status of selected genes in non-small cell lung carcinoma - current knowledge and future perspectives. | Neoplasma | 2024 | 39832203 | PubTator, text mining | PubMed |
| Therapeutic Exploitation of Neuroendocrine Transdifferentiation Drivers in Prostate Cancer. | Cells | 2024 | 39682746 | PubTator, text mining | PubMed |
| Novel Immunohistochemical Profiling of Small-Cell Lung Cancer: Correlations Between Tumor Subtypes and Immune Microenvironment. | Diagnostics (Basel) | 2024 | 39682568 | PubTator, text mining | PubMed |
| Editorial: Pancreatic beta-cell dedifferentiation. | Front Endocrinol (Lausanne) | 2024 | 39678191 | PubTator, text mining | PubMed |
| The people behind the papers - Roberta Azzarelli and Anna Philpott. | Development | 2024 | 39665409 | PubTator, text mining | PubMed |
| Chemical transdifferentiation of somatic cells to neural cells: a systematic review. | Einstein (Sao Paulo) | 2024 | 39661857 | PubTator, text mining | PubMed |
| Regulation of neuronal fate specification and connectivity of the thalamic reticular nucleus by the Ascl1-Isl1 transcriptional cascade. | Cell Mol Life Sci | 2024 | 39625482 | PubTator, text mining | PubMed |
| A Snapshot of Early Transcriptional Changes Accompanying the Pro-Neural Phenotype Switch by NGN2, ASCL1, SOX2, and MSI1 in Human Fibroblasts: An RNA-Seq Study. | Int J Mol Sci | 2024 | 39596450 | PubTator, text mining | PubMed |
| PGC-1α drives small cell neuroendocrine cancer progression toward an ASCL1-expressing subtype with increased mitochondrial capacity. | Proc Natl Acad Sci U S A | 2024 | 39589879 | PubTator, text mining | PubMed |
| Orexin-A increases the differentiation of human olfactory sensory neurons through orexin receptor type 1. | Regen Ther | 2024 | 39582799 | PubTator, text mining | PubMed |
| Phospho-regulation of ASCL1-mediated chromatin opening during cellular reprogramming. | Development | 2024 | 39575884 | PubTator, text mining | PubMed |
| The molecular subtypes of small cell lung cancer defined by key transcription factors and their clinical significance. | Lung Cancer | 2024 | 39571251 | PubTator, text mining | PubMed |
| A Transcriptional Signature of Induced Neurons Differentiates Virologically Suppressed People Living With HIV from People Without HIV. | bioRxiv | 2024 | 39484396 | PubTator, text mining | PubMed |
| ASCL1 regulates and cooperates with FOXA2 to drive terminal neuroendocrine phenotype in prostate cancer. | JCI Insight | 2024 | 39470735 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/429/papers?page=15